These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 11396281)

  • 21. Population pharmacokinetics of lorazepam and midazolam and their metabolites in intensive care patients on continuous venovenous hemofiltration.
    Swart EL; de Jongh J; Zuideveld KP; Danhof M; Thijs LG; Strack van Schijndel RJ
    Am J Kidney Dis; 2005 Feb; 45(2):360-71. PubMed ID: 15685515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics and dosing regimen of meropenem in critically ill patients receiving continuous venovenous hemofiltration.
    Ververs TF; van Dijk A; Vinks SA; Blankestijn PJ; Savelkoul JF; Meulenbelt J; Boereboom FT
    Crit Care Med; 2000 Oct; 28(10):3412-6. PubMed ID: 11057794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Levofloxacin pharmacokinetics in ESRD and removal by the cellulose acetate high performance-210 hemodialyzer.
    Sowinski KM; Lucksiri A; Kays MB; Scott MK; Mueller BA; Hamburger RJ
    Am J Kidney Dis; 2003 Aug; 42(2):342-9. PubMed ID: 12900817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The effect of continuous veno venous hemofiltration on neutrophil gelatinase-associated lipocalin plasma levels in critically ill patients with acute kidney injury].
    Wang H; Cui N; Zhou YK; Cheng W; Li L; Long Y; Liu DW
    Zhonghua Nei Ke Za Zhi; 2018 Apr; 57(4):285-289. PubMed ID: 29614588
    [No Abstract]   [Full Text] [Related]  

  • 25. The clinical pharmacokinetics of levofloxacin.
    Fish DN; Chow AT
    Clin Pharmacokinet; 1997 Feb; 32(2):101-19. PubMed ID: 9068926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amino acid loss and nitrogen balance in critically ill children with acute renal failure: a prospective comparison between classic hemofiltration and hemofiltration with dialysis.
    Maxvold NJ; Smoyer WE; Custer JR; Bunchman TE
    Crit Care Med; 2000 Apr; 28(4):1161-5. PubMed ID: 10809299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pharmacokinetic profile of voriconazole during continuous high-volume venovenous hemofiltration in a critically ill patient.
    Quintard H; Papy E; Massias L; Lasocki S; Arnaud P; Desmonts JM; Montravers P
    Ther Drug Monit; 2008 Feb; 30(1):117-9. PubMed ID: 18223474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics and safety of oral levofloxacin in human immunodeficiency virus-infected individuals receiving concomitant zidovudine.
    Chien SC; Chow AT; Rogge MC; Williams RR; Hendrix CW
    Antimicrob Agents Chemother; 1997 Aug; 41(8):1765-9. PubMed ID: 9257757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of meropenem in critically ill patients with acute renal failure undergoing continuous venovenous hemofiltration.
    Tegeder I; Neumann F; Bremer F; Brune K; Lötsch J; Geisslinger G
    Clin Pharmacol Ther; 1999 Jan; 65(1):50-7. PubMed ID: 9951430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of imipenem-cilastatin in critically ill patients undergoing continuous venovenous hemofiltration.
    Tegeder I; Bremer F; Oelkers R; Schobel H; Schüttler J; Brune K; Geisslinger G
    Antimicrob Agents Chemother; 1997 Dec; 41(12):2640-5. PubMed ID: 9420033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma concentrations and clearance of procalcitonin during continuous veno-venous hemofiltration in septic patients.
    Meisner M; Hüttemann E; Lohs T; Kasakov L; Reinhart K
    Shock; 2001 Mar; 15(3):171-5. PubMed ID: 11236898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Teicoplanin pharmacokinetics in critically ill patients on continuous veno-venous hemofiltration.
    Bellmann R; Falkensammer G; Seger C; Weiler S; Kountchev J; Joannidis M
    Int J Clin Pharmacol Ther; 2010 Apr; 48(4):243-9. PubMed ID: 20353745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Removal of piperacillin in critically ill patients undergoing continuous venovenous hemofiltration.
    Capellier G; Cornette C; Boillot A; Guinchard C; Jacques T; Blasco G; Barale F
    Crit Care Med; 1998 Jan; 26(1):88-91. PubMed ID: 9428548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of cefpirome during continuous venovenous hemofiltration: rationale for an 8-hour dosing interval.
    Banyai M; Thalhammer F; El-Menyawi I; Heinz G; Traunmüller F; Siostrzonek P
    Clin Pharmacol Ther; 2000 Apr; 67(4):368-72. PubMed ID: 10801245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Steady-state plasma and intrapulmonary concentrations of levofloxacin and ciprofloxacin in healthy adult subjects.
    Gotfried MH; Danziger LH; Rodvold KA
    Chest; 2001 Apr; 119(4):1114-22. PubMed ID: 11296178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of amikacin during continuous veno-venous hemofiltration.
    Armendariz E; Chelluri L; Ptachcinski R
    Crit Care Med; 1990 Jun; 18(6):675-6. PubMed ID: 2344762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Removal of linezolid by conventional intermittent hemodialysis, sustained low-efficiency dialysis, or continuous venovenous hemofiltration in patients with acute renal failure.
    Fiaccadori E; Maggiore U; Rotelli C; Giacosa R; Parenti E; Picetti E; Sagripanti S; Manini P; Andreoli R; Cabassi A
    Crit Care Med; 2004 Dec; 32(12):2437-42. PubMed ID: 15599148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and pharmacokinetics of multiple 750-milligram doses of intravenous levofloxacin in healthy volunteers.
    Chow AT; Fowler C; Williams RR; Morgan N; Kaminski S; Natarajan J
    Antimicrob Agents Chemother; 2001 Jul; 45(7):2122-5. PubMed ID: 11408234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple-dose pharmacokinetics of anidulafungin during continuous venovenous haemofiltration.
    Leitner JM; Meyer B; Fuhrmann V; Saria K; Zuba C; Jäger W; Böhmdorfer M; Thalhammer F
    J Antimicrob Chemother; 2011 Apr; 66(4):880-4. PubMed ID: 21393208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and intrapulmonary diffusion of levofloxacin in critically ill patients with severe community-acquired pneumonia.
    Boselli E; Breilh D; Rimmelé T; Djabarouti S; Saux MC; Chassard D; Allaouchiche B
    Crit Care Med; 2005 Jan; 33(1):104-9. PubMed ID: 15644655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.